Possible therapeutic window for serotonin reuptake inhibitors
Fichtner, C.G.; Jobe, T.H.; Braun, B.G.
Journal of Clinical Psychiatry 55(1): 36-38
1994
ISSN/ISBN: 0160-6689 PMID: 8294393 Document Number: 434448
Document emailed within 1 workday
Related Documents
Posternak, M.A.; Zimmerman, M. 2005: Dual reuptake inhibitors incur lower rates of tachyphylaxis than selective serotonin reuptake inhibitors: a retrospective study Journal of Clinical Psychiatry 66(6): 705-707Leonard, B.E. 1988: Pharmacological effects of serotonin reuptake inhibitors Journal of Clinical Psychiatry 49 Suppl: 12-17
DeVane, C.L. 1992: Pharmacokinetics of the selective serotonin reuptake inhibitors Journal of Clinical Psychiatry 53 Suppl: 13-20
Mayer, L.E.; Walsh, B.T. 1998: The use of selective serotonin reuptake inhibitors in eating disorders Journal of Clinical Psychiatry 59(Suppl): 28-34
Mahendran, R. 2006: The risk of suicidality with selective serotonin reuptake inhibitors Annals of the Academy of Medicine Singapore 35(2): 96-99
Dudek, D.; Zieba, A.; Siwek, M.; Wróbel, A. 2004: Selective serotonin reuptake inhibitors--current knowledge Psychiatria Polska 38(3): 507-524
Eriksson, E. 1999: Serotonin reuptake inhibitors for the treatment of premenstrual dysphoria International Clinical Psychopharmacology 14(Suppl 2): S27-S33
Dubovsky, S.L. 1994: Beyond the serotonin reuptake inhibitors: rationales for the development of new serotonergic agents Journal of Clinical Psychiatry 55(Suppl): 34-44
Sheehan, D.V.; Zak, J.P.; Miller, J.A.; Fanous, B.S. 1988: Panic disorder: the potential role of serotonin reuptake inhibitors Journal of Clinical Psychiatry 49 Suppl: 30-36
Condat, A.; Mouren-Simeoni, M.C. 2000: Selective serotonin reuptake inhibitors and depression in the child and adolescent L'Encephale 26(3): 53-60
Nakielny, J.; Eckett, S. 1994: Selective serotonin reuptake inhibitors. Calculation of costs is incorrect Bmj 309(6961): 1082-3; Author Reply 1085
Ostroff, R.B.; Nelson, J.C. 1999: Risperidone augmentation of selective serotonin reuptake inhibitors in major depression Journal of Clinical Psychiatry 60(4): 256-259
Zajecka, J.; Tracy, K.A.; Mitchell, S. 1997: Discontinuation symptoms after treatment with serotonin reuptake inhibitors: a literature review Journal of Clinical Psychiatry 58(7): 291-297
Tracey, D. 1994: Selective serotonin reuptake inhibitors. Commercial interests should not influence prescribing Bmj 309(6961): 1083-4; Author Reply 1085
Nelson, S.A.; Wilson, G.A.; Tucci, M.; Benghuzzi, H. 2015: The Effect of Selective Serotonin Reuptake Inhibitors and Antidiabetic Drugs on Cardiomyocytes Biomedical Sciences Instrumentation 51: 400-406
Joffe, R.T.; Schuller, D.R. 1993: An open study of buspirone augmentation of serotonin reuptake inhibitors in refractory depression Journal of Clinical Psychiatry 54(7): 269-271
Fonzo-Christe, C.; Vogt, N. 2000: Susceptibility of the elderly patient to hyponatremia induced by selective serotonin reuptake inhibitors Therapie 55(5): 597-604
Korendovych, I.V.; Svintsits'kyĭ, A.S.; Revenok, K.M.; Maliarov, S.O. 2014: Psychopharmacological approach with the usage of selective serotonin reuptake inhibitors in functional dyspepsia treatment Likars'ka Sprava 11: 58-64
Van Ermen, A.M.; Ottervanger, J.P.; Roisin, T.; Kurz, X.; Stricker, B.H. 1996: Reports of suspected side effects of selective serotonin reuptake inhibitors in Belgium and The Netherlands Nederlands Tijdschrift Voor Geneeskunde 140(36): 1817-1820
Phillips, K.A. 1996: An open study of buspirone augmentation of serotonin-reuptake inhibitors in body dysmorphic disorder Psychopharmacology Bulletin 32(1): 175-180